• 靶点：
• AGXT2L2

• 简介：
• >>Lysine degradation;>>Metabolic pathways

• 基因名称：
• AGXT2L2

• 蛋白名称：
• 5-phosphohydroxy-L-lysine phospho-lyase

• Human Gene Id：
• 85007

• Human Swiss Prot No：
• Q8IUZ5

• Mouse Gene Id：
• 72947

• Mouse Swiss Prot No：
• Q8R1K4

• 免疫原：
• The antiserum was produced against synthesized peptide derived from human AGXT2L2. AA range:341-390

• 特异性：
• AGXT2L2 Polyclonal Antibody detects endogenous levels of AGXT2L2 protein.

• 组成：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• 来源：
• Polyclonal, Rabbit,IgG

• 稀释：
• WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:10000.. IF 1:50-200

• 纯化工艺：
• The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• 浓度：
• 1 mg/ml

• 储存：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• 其他名称：
• AGXT2L2;PP9286;5-phosphohydroxy-L-lysine phospho-lyase;Alanine--glyoxylate aminotransferase 2-like 2

• 实测条带：
• 50kD

• 背景：
• 5-phosphohydroxy-L-lysine phospho-lyase(PHYKPL) Homo sapiens This is a nuclear gene encoding a mitochondrial enzyme that catalyzes the conversion of 5-phosphonooxy-L-lysine to ammonia, inorganic phosphate, and 2-aminoadipate semialdehyde. Mutations in this gene may cause phosphohydroxylysinuria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013],

• 功能：
• cofactor:Pyridoxal phosphate .,similarity:Belongs to the class-III pyridoxal-phosphate-dependent aminotransferase family.,subunit:Homotetramer.,

• 细胞定位：
• Mitochondrion .

• 组织表达：
• Brain,Muscle,Pancreas,Stomach,

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs